Dear Scientist, Clinician or Visitor,

Welcome to MiSOT, our specialist Consortium focused on the use of mesenchymal stem cells (MSC) and related multipotent adult progenitor cells (MAPC) in the field of solid organ transplantation.

MiSOT aims to bring together academic and commercial research with the goal of bringing mesenchymal stem cell therapies to the transplantation clinic. We organize yearly meetings, position papers and inter-laboratory exchange and always try to find new funding and publication possibilities.

This platform will also be used to update on the latest clinical trial protocols and scientific news.

Please contact us via the website or get in touch with one of the partner labs directly.


Prof. Marc-H Dahlke
MiSOT Group Leader
University Hospital Regensburg